Wednesday, October 14, 2015

23andMe Gets $115M From Fidelity, Others

Mountain View-based genetics analysis developer 23andMe says this morning that it has raised a big, $115M Series E funding round, led by Fidelity Management & Research Company. The funding also included Casdin Capital, WuXi Healthcare Ventures and Xfund, plus Illumina, New Enterprise Associates, MPM Capital, and Google Ventures. 23andMe said the funding goes towards expanding its operations, plus new laboratory space, a sequencing laboratory, and more. More information »